Workspace / Industry lens/Pharma & Healthcare
Prices to 11 Sept 2026 · Financials to 30 Jun 2026 · Developments 13 Sept 2026
Industry lens / Sector

Pharma & Healthcare

14 companies tracked across large, mid and small caps.

What drives this industry

0 of 2 collected
Pharmaceutical exports

Not collected yet. Source: Ministry of Commerce · published monthly.

Export demand, especially US generics, drives most of the listed names.

USFDA actions on Indian sites

Not collected yet. Source: US FDA · published monthly.

A warning letter or import alert can shut a plant's revenue off overnight.

How the tracked companies have fared

Price returns across our universe in this sector — not an index
Average 1-year return
+24.2%

Mean across 14 companies

Average 1-month return
-1.5%

Equally weighted

Developments reported
75

Material items in the last 7 days

Sign in to see every company in this sector

Guests see a sample. Members get every company, five-year fundamentals, classified developments, a watchlist and the decision journal.

Sign in with Google

Developments in this sector

Reads negativeRegulatoryyesterday

USFDA Issues Two Observations After Records Assessment of Dr. Reddy's Mexico API Facility

Medical Dialogues13 Sept 2026, 6:00 pm IST
Classification & context · Moves the numbers

The headline states a business fact and a direction that hurts it. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.80. This is not the probability that the report is true.

Neutralyesterday

Apollo Hospitals Navi Mumbai introduces geriatric oncology clinic

Medical Dialogues13 Sept 2026, 2:45 pm IST
Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutralyesterday

Nifty may rebound to 23,800; Rupak De picks Apollo, Laurus Labs and Eternal for the week

The Economic Times13 Sept 2026, 1:22 pm IST
Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Reads positiveRevenueyesterday

Cipla reports record Q1FY27 revenue of ₹7,119 crore

scanx.trade13 Sept 2026, 1:15 pm IST
Classification & context · Moves the numbers

The headline states a business fact and a direction that helps it. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.75. This is not the probability that the report is true.

NeutralRevenueyesterday

Cipla records highest revenue of ₹28,000 crore in FY26

scanx.trade13 Sept 2026, 1:15 pm IST
Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

NeutralRevenueyesterday

Lupin eyes $500 mn biosimilars revenue in medium term, to ramp capacity

Business Standard13 Sept 2026, 12:27 pm IST
Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

NeutralEarningsyesterday

Aurobindo Pharma AGM results: ₹4 dividend confirmed, K. Nithyananda Reddy reappointed amid dissent

scanx.trade13 Sept 2026, 11:53 am IST
Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutralyesterday

Sanjeev Kathuria Appointed Director, Business Unit Head – Oncology Cluster at Cipla

hrtoday.in13 Sept 2026, 11:44 am IST
Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutralyesterday

Dr. Reddy's Laboratories Limited rStock (RRDY) Price Prediction for 2026 to 2031

Bybit13 Sept 2026, 8:50 am IST
Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutralyesterday

Bhushan Malpure elevated to Head of Marketing at Cipla

Indian Pharma Post13 Sept 2026, 6:56 am IST
Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutralyesterday

HBA India Summit puts spotlight on India’s rising role in global healthcare leadership

Indian Pharma Post13 Sept 2026, 6:55 am IST
Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutralyesterday

Commerce Minister urges pharma industry to utilise FTA opportunities for building India global destination for medicines

newsonair.gov.in13 Sept 2026, 3:29 am IST
Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral2 days ago

Sun Pharma Subsidiaries Settle with Plaintiff in US Generic Drug Pricing Litigation

Medical Dialogues12 Sept 2026, 9:30 pm IST
Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral2 days ago

Tech Query: Lupin, KFin Technologies, KPI Green Energy, Goodluck India - What is the outlook? Where are these stocks headed?

thehindubusinessline.com12 Sept 2026, 8:42 pm IST
Classification & context · Commentary

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Somebody's reading of events rather than an event. Worth the argument; not a filing.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral2 days ago

Invesco India Pharma And Healthcare Fund Regular-Growth

The Economic Times12 Sept 2026, 6:48 pm IST
Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral2 days ago

Manipal Health Enterprises Ltd Share Price Today,, MANIPALHOS Share Price NSE, BSE

Business Today12 Sept 2026, 4:15 pm IST
Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral2 days ago

Credent Connect N Care Ltd (CREDENT) Share Price

Business Today12 Sept 2026, 3:28 pm IST
Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral2 days ago

Wellington Management Group LLP Cuts Position in Dr. Reddy's Laboratories Ltd $RDY

marketbeat.com12 Sept 2026, 1:57 pm IST
Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral2 days ago

Laurus Labs Share Price at fresh 52-week high, Rs 1,974

Univest12 Sept 2026, 1:39 pm IST
Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral2 days ago

Apollo Hospitals Chennai Performs India’s First Procedure Using LigaSure RAS with Hugo Robotic System

Apollo Hospitals12 Sept 2026, 1:26 pm IST
Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

NeutralM&A2 days ago

Aurobindo Pharma acquires 100% stake in A1 Biochem USA for $1 million

scanx.trade12 Sept 2026, 1:17 pm IST
Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

NeutralM&A2 days ago

AUROBINDO PHARMA: Acquires 100% Stake in US Subsidiary

InvestyWise12 Sept 2026, 12:53 pm IST
Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral2 days ago

Aurobindo Pharma AUROPHARMA: A1 Biochem USA Inc Setup

Kalkine India12 Sept 2026, 12:41 pm IST
Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral2 days ago

Top 14 Pharma Stocks To Buy In India September 2026

Samco12 Sept 2026, 12:21 pm IST
Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral2 days ago

Invesco India Pharma And Healthcare Fund Direct-IDCW

The Economic Times12 Sept 2026, 12:02 pm IST
Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral2 days ago

Divi's Laboratories (NSE:DIVISLAB): What Is the Special Window for Physical Share Transfer and Dematerialisation?

Kalkine India12 Sept 2026, 12:02 pm IST
Classification & context · Commentary

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Somebody's reading of events rather than an event. Worth the argument; not a filing.

Classifier confidence: 0.35. This is not the probability that the report is true.

NeutralOrders2 days ago

Granules India promoter sells 1.72 crore shares in block deal

scanx.trade12 Sept 2026, 11:51 am IST
Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

Reads negativeRegulatory2 days ago

Dr. Reddy’s Labs Receives Two USFDA Observations For Mexico API Facility Records Assessment

Sahi12 Sept 2026, 10:44 am IST
Classification & context · Moves the numbers

The headline states a business fact and a direction that hurts it. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.80. This is not the probability that the report is true.

Neutral2 days ago

Dr Reddy’s US food and drug administration inspection of Mexico facility ends with two observations

Telegraph India12 Sept 2026, 9:35 am IST
Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral2 days ago

India-UK CETA Could Put Maharashtra At The Centre Of Healthcare Investment

BW Healthcare World12 Sept 2026, 8:44 am IST
Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Developments are classified by their likely business effect where the evidence supports one. Counting them does not measure the industry: for that, read the drivers above.